Paul D. Thompson MD
Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, ConnecticutDr. Paul Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut in Storrs. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992.
He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors; the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function; and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia.
Dr. Thompson is the co-editor of the book Exercise and Sports Cardiology and of the book Statin-Associated Muscle Symptoms. He is a past president of the American College of Sports Medicine.
Disclosures
- Consultant: Legal consultation on exercise-related cardiac events and statin myopathy
- Research funding: Esperion; Novartis
- Financial interests: Abbott Labs; CVS; Illumina; Novo-Nordisk; GE Healthcare; Johnson & Johnson; Medtronic; OpSens; scPharmaceuticals; Sarepta; Shockwave Medical
Recent Contributions to PracticeUpdate:
- Etiology of Sudden Death in Sports
- Cardiopulmonary Exercise Testing in Specific Patient Populations
- Right and Left Ventricular Function and Mass in Male Elite Master Athletes
- Current Strategies and Recommendations for College Student-Athletes
- Evolocumab Superior to Ezetimibe in Patients With Muscle-Related Statin Intolerance
- Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure
- High Exercise Capacity Attenuates the Risk of Early Mortality After a First Myocardial Infarction
- Prognostic Value of Exercise Capacity and Fitness-Associated Biologic Age
- Exercise-Based Rehabilitation for Coronary Heart Disease
- 2015 Top Stories in Cardiology: Preventive Cardiology